SEARCH RESULT

Total Matching Records found : 1736

Right to affordable drugs upheld: activists-Aarti Dhar

-The Hindu   "The court has recognised the right of patients to access affordable medicines over profits for big pharma companies" It was celebration time for health activists and civil society groups after the Supreme Court delivered its judgment dismissing Swiss multinational company Novartis' appeal for patent for its anti-cancer medicine imatinib mesylate or Gleevec. "We are happy that the apex court has recognised the right of patients to access affordable medicines over profits...

More »

Supreme Court rules for cheap cancer drug -Subodh Varma

-The Times of India The Supreme Court on Monday rejected pharma giant Novartis AG's plea to preserve its patent over a life-saving cancer drug, Glivec, drawing a huge sigh of relief from thousands of patients in India and in dozens of developing countries as the fear of an almost 15-fold escalation of drug costs receded. It is the biggest setback for multinational pharma companies, which have been denied patent protection...

More »

Patent war over drugs goes chronic -Rupali Mukherjee

-The Times of India MUMBAI: Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...

More »

Agriculture vs technology -Deepak Pental

-The Indian Express No country has ever achieved prosperity without engaging with science and technology (S&T). The ascent of the West and its global domination owes much to its prowess in S&T. In Asia, Japan and South Korea and more recently China have taken the highway to prosperity by mastering technology and effectively dealing with complexity. Chinese economist Justin Yufi Lin in his book The Quest for Prosperity has argued that...

More »

'Delayed diagnosis a major challenge in TB control'-Aarti Dhar

-The Hindu India may have achieved a success rate of 88 per cent in treatment of tuberculosis - higher than the global treatment success rate of 85 per cent - but HIV-TB co-infection continues to be a cause of major concern, as the percentage of people infected with the twin infection increased substantially between 2010 and 2011. The percentage of TB patients tested for HIV increased nationally from 32 per cent...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close